Home » Topics » BioWorld Science

BioWorld Science
RSS

Harvard Scientific seeks to proceed with clinical trials on erectile dysfunction Rx

Nov. 29, 1996

Sorin to market Bard diagnostic test

Nov. 29, 1996

DepoTech begins filing NDA for DepoCyt

Nov. 29, 1996

Negative clinical results reported for aromatase inhibitor in BPH

Nov. 29, 1996

3DP seeks partners for receptor-based drug discovery program

Nov. 29, 1996

Anticancer compound from AEterna enters the clinic

Nov. 29, 1996

Corporate partners sought for drug discovery collaboration based on 3DP technology

Nov. 29, 1996

Partners sought for 3DP MHC blockers

Nov. 29, 1996

3DP seeks partners for potential treatments for retinopathies and cancer

Nov. 29, 1996

3DP seeks partners for protease inhibitor discovery program

Nov. 29, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...